DAT imaging in drug-induced and psychogenic parkinsonism.
about
Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced ParkinsonismDifferential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CTClinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.Recognizing uncommon presentations of psychogenic (functional) movement disorders.Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism.Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonismPsychogenic parkinsonismPsychogenic movement disorders: past developments, current status, and future directions.The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.The sensitivity and specificity of F-DOPA PET in a movement disorder clinic.What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder.[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration.Microstructural white matter alterations in patients with drug induced parkinsonism.Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy.Tremor analysis separates Parkinson's disease and dopamine receptor blockers induced parkinsonism.Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor.Risk for antipsychotic-induced extrapyramidal symptoms: influence of family history and genetic susceptibility.[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson’s Disease from Other Parkinsonian Syndromes.
P2860
Q28468282-D65E1C80-23C7-4A71-BDF9-B34DE6991EE9Q33639396-4B5D36F4-40DB-4C82-87CF-CD50B654BDE0Q33790729-B263D62B-B8CA-42D1-9B0B-AF8C3990E7D2Q35002512-279C6065-7BFC-4A7A-9829-49DF47E04B0FQ36143071-5BB0557F-3968-4284-B6F7-DC09E77163BEQ36226750-F08B4EBC-B076-48CE-B931-2E870D2A9CBAQ37860579-B0C74510-86DF-4158-BC34-90C2199BCD9AQ37882605-FD9A7051-57D9-416B-A7BC-9F3D7B5C29E6Q37910636-7A4819D6-3E09-4978-83EA-F682CF3C7810Q38358021-0BEF7A02-D449-4E90-BEFB-0133915AE31EQ38492560-996CD2DC-99DA-4BF2-9248-99234CC0D262Q45076686-CBD09A16-9ED7-435E-A025-6081EC202399Q46775404-D477EBA0-653A-4282-9356-484D4C4C1BB2Q46789080-B0C42463-F82A-48F4-9F11-1747802BCBC0Q47681149-650E0ACA-44A6-454E-8BCD-8CD0DDD93140Q48534930-64CB3467-88FB-41AD-9EAD-73F496479DA3Q48739193-ABA087E6-028C-41E3-ACB5-29C49FC0207DQ50240519-B758B538-B349-4DCF-A9BE-8E6A0EB227E2Q50936610-B96B04D1-030C-4F02-A443-B57B7D9C27DBQ51829015-547874FB-D394-4648-8BFD-3A8DDC2485ABQ53067649-BC835810-D8BB-48AB-B7C0-FD6305645E1FQ55344774-68A2EAC7-BAB7-45A2-819E-C809483FD5E8
P2860
DAT imaging in drug-induced and psychogenic parkinsonism.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
DAT imaging in drug-induced and psychogenic parkinsonism.
@ast
DAT imaging in drug-induced and psychogenic parkinsonism.
@en
type
label
DAT imaging in drug-induced and psychogenic parkinsonism.
@ast
DAT imaging in drug-induced and psychogenic parkinsonism.
@en
prefLabel
DAT imaging in drug-induced and psychogenic parkinsonism.
@ast
DAT imaging in drug-induced and psychogenic parkinsonism.
@en
P2860
P356
P1433
P1476
DAT imaging in drug-induced and psychogenic parkinsonism.
@en
P2093
Marisol Gallardo
Miguel Coelho
P2860
P304
P356
10.1002/MDS.10575
P407
P478
18 Suppl 7
P577
2003-10-01T00:00:00Z